1. Home
  2. PHR vs EMBC Comparison

PHR vs EMBC Comparison

Compare PHR & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Phreesia Inc.

PHR

Phreesia Inc.

HOLD

Current Price

$10.87

Market Cap

713.2M

ML Signal

HOLD

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$8.85

Market Cap

602.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PHR
EMBC
Founded
2005
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
713.2M
602.3M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
PHR
EMBC
Price
$10.87
$8.85
Analyst Decision
Strong Buy
Buy
Analyst Count
17
2
Target Price
$30.65
$18.50
AVG Volume (30 Days)
1.6M
801.9K
Earning Date
01-01-0001
05-11-2026
Dividend Yield
N/A
6.81%
EPS Growth
59.36
20.90
EPS
0.02
0.74
Revenue
$419,813,000.00
N/A
Revenue This Year
$15.54
$1.17
Revenue Next Year
$15.04
N/A
P/E Ratio
$550.00
$11.91
Revenue Growth
17.83
N/A
52 Week Low
$10.99
$8.77
52 Week High
$32.76
$15.55

Technical Indicators

Market Signals
Indicator
PHR
EMBC
Relative Strength Index (RSI) 27.92 32.27
Support Level N/A N/A
Resistance Level $12.84 $10.88
Average True Range (ATR) 0.58 0.33
MACD 0.00 -0.07
Stochastic Oscillator 1.48 3.87

Price Performance

Historical Comparison
PHR
EMBC

About PHR Phreesia Inc.

Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: